logo

Lilly Lebanon Manufacturing Facilities Expansion

Sector: Manufacturing (Industrial) • Location: Lebanon, Indiana, United States

Source: Powder & Bulk Solids

Project
Planned

Eli Lilly and Co. is investing $4.5 billion to expand two manufacturing sites in Lebanon, Indiana. The expansion includes new process designs and technologies at the Lilly Lebanon API site, a future active pharmaceutical ingredient manufacturing site, and the Lilly Lebanon Advanced Therapies facility, the company's first dedicated genetic medicine manufacturing facility. The Advanced Therapies fac

Project Information FAQ

Project Information

4 Q
The project “Lilly Lebanon Manufacturing Facilities Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Lebanon, Indiana, United States. Taiyo aggregates data on it from Powder & Bulk Solids.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

planned

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Eli Lilly and Co. is investing $4.5 billion to expand two manufacturing sites in Lebanon, Indiana. The expansion includes new process designs and technologies at the Lilly Lebanon API site, a future active pharmaceutical ingredient manufacturing site, and the Lilly Lebanon Advanced Therapies facility, the company's first dedicated genetic medicine manufacturing facility. The Advanced Therapies facility will support clinical and commercial production of advanced genetic therapies, covering research-stage development through large-scale commercial supply. This expansion is part of a larger commitment to domestic manufacturing in Indiana, with plans to produce several pharmaceutical products including Foundayo, Lilly's first FDA-approved pill for weight loss.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data